Elevance Health/$ELV
1D1W1MYTD1Y5YMAX
Capital at risk
About Elevance Health
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
- Ticker
- $ELV
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 96,615
- Headquarters
- Indianapolis, United States
- Website
- www.elevancehealth.com
Elevance Health Metrics
BasicAdvanced
$86B
17.72
$22.47
0.70
$5.15
1.73%
Price and volume
Market cap
$86B
Beta
0.7
52-week high
$436.24
52-week low
$274.84
Average daily volume
1.1M
Dividend rate
$5.15
Financial strength
Current ratio
1.518
Quick ratio
1.376
Long term debt to equity
0.681
Total debt to equity
0.69
Dividend payout ratio (TTM)
30.36%
Interest coverage (TTM)
5.29%
Profitability
EBITDA (TTM)
8,324
Gross margin (TTM)
25.99%
Net profit margin (TTM)
2.47%
Operating margin (TTM)
3.79%
Effective tax rate (TTM)
15.61%
Revenue per employee (TTM)
$2,080,000
Management effectiveness
Return on assets (TTM)
3.83%
Return on equity (TTM)
11.13%
Valuation
Price to earnings (TTM)
17.721
Price to revenue (TTM)
0.436
Price to book
1.92
Price to tangible book (TTM)
15.53
Price to free cash flow (TTM)
13.928
Free cash flow yield (TTM)
7.18%
Free cash flow per share (TTM)
28.593
Dividend yield (TTM)
1.29%
Forward dividend yield
1.73%
Growth
Revenue change (TTM)
6.27%
Earnings per share change (TTM)
-3.90%
3-year revenue growth (CAGR)
6.67%
10-year revenue growth (CAGR)
9.40%
3-year earnings per share growth (CAGR)
-5.08%
10-year earnings per share growth (CAGR)
10.02%
3-year dividend per share growth (CAGR)
7.51%
10-year dividend per share growth (CAGR)
10.40%
What the Analysts think about Elevance Health
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Analyst projections of the future price of Elevance Health stock.
Bulls say / Bears say
Elevance exceeded Q2 2026 expectations, posting adjusted EPS of $7.45 versus a $6.18 consensus, and raised full-year adjusted EPS guidance to at least $27 from at least $26.75. (Bloomberg Law)
Higher premium yields in Health Benefits and continued CarelonRx product-revenue growth are helping offset membership declines, indicating that pricing and the diversified services platform can support revenue quality. (Elevance Health)
Management raised 2026 operating-cash-flow guidance to at least $6.0 billion and is accelerating investments in medical-cost management, operating efficiency, provider connectivity, and Carelon value-based solutions, which could improve earnings durability and shareholder-return capacity. (SEC)
Medical membership fell by 469,000 sequentially to approximately 44.9 million in Q2 2026, with further declines expected in Medicare Advantage, Medicaid, and employer risk membership; this creates revenue and operating-leverage pressure. (Elevance Health)
Medicaid medical-cost pressure remains a material headwind: Elevance reported increasing Medicaid costs in Q1, while its benefit expense ratio rose and management continued investing to improve cost control. (Bloomberg)
The Q2 adjusted-EPS guidance increase to at least $27 was smaller than investors expected, suggesting ongoing profitability risks from healthcare-cost inflation and recent federal policy changes despite the earnings beat. (Bloomberg Law)
Data summarised monthly by Lightyear AI. Last updated on 10 Sept 2026.
Elevance Health Financial Performance
Revenues and expenses
Elevance Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Elevance Health News
AllArticlesVideos
Funds containing Elevance Health
AllEURUSDGBP
Fund name | Fund size | $ELV weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.48% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.41% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.60% |
iShares MSCI USA SRI€QDVR | €2.9B | 0.60% |
iShares MSCI USA SRI£SUUS | £2.5B | 0.60% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.